New Key Statistics Module, Z-Score and F-Score
NYSE:DNA Key Ratios
| Market Cap $ M | 473.40 |
| Enterprise Value $ M | 575.35 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.07 |
| Price/Sales | 3.61 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 111.00 |
| EPS (TTM) $ | -5.01 |
| Beneish M-Score | -3.27 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -51.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.93 |
| EV-to-EBITDA | -2.36 |
| PEG | -- |
| Shares Outstanding M | 67.34 |
| Net Margin (%) | -259.96 |
| Operating Margin % | -257.67 |
| Pre-tax Margin (%) | -264.15 |
| Quick Ratio | 4.57 |
| Current Ratio | 4.57 |
| ROA % (ttm) | -26.14 |
| ROE % (ttm) | -57.14 |
| ROIC % (ttm) | -41.38 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.95 |
DNA Number of Guru Trades
DNA Volume of Guru Trades
Gurus Latest Trades with NYSE:DNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:DNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ginkgo Bioworks Holdings Inc Insider Transactions
No Available Data
News about NYSE:DNA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers